Skip to main content

Table 3 Main toxicity in 70 patients

From: FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort

Toxicity

Grade 3 (%)

Grade 4 (%)

Neutropeniaa

21.5

7

Anemia

7

-

Thrombocytopenia

3

-

Diarrhea

13

1.4

Nausea/vomiting

6

-

Mucositis

6

-

Fatigue

6

-

Hepatotoxicity

3

-

  1. aFour episodes of febrile neutropenia in 3 patients (4%).
Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us